Home / Technology & Devices (page 42)

Technology & Devices

Sanofi and Innate Pharma Collaborate to Develop Next Generation ADCs

Sanofi is teaming up with Innate Pharma to use its technology for development of new antibody drug conjugates (ADC). Today, France’s Innate Pharma announced that it has entered into a collaboration agreement to apply Innate’s site-specific conjugation technology to the development of new ADC. The companies did not disclose financial …

Read More »

Veracyte and GE Partner to Develop New Diagnostic Approaches

Molecular diagnostic company Veracyte, Inc. announced it is teaming up with GE to develop new diagnostic approaches to address unmet clinical needs. Veracyte and GE announced a research collaboration to develop new solutions that can improve disease diagnosis. Veracyte will collaborate with GE Ventures, GE Healthcare and the GE Global …

Read More »

Roche’s Ventana Enters Deal to Develop Companion Diagnostic Test for Astellas Cancer Compound

Roche’s Ventana Medical Systems has inked a deal with Astellas Pharma aimed at developing new diagnostic tests for targeted cancer treatments. The cancer diagnostics company announced that it has entered into master collaboration agreement with Astellas Pharma to develop novel automated tissue diagnostics in support of therapeutic compounds in development. …

Read More »

Roche Acquires Genomics Research Company CAPP Medical

Roche has acquired a Stanford University-founded genomics research company, CAPP Medical, in an effort to strengthen its oncology translational research pipeline. The company announced today that it has acquired CAPP Medical to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) …

Read More »

TGen Uses Personalized Medicine to Discover Genetic Source of Muscle Weakness in Children

State-of-the-art genetic technology has allowed scientists at the Translational Genomics Research Institute (TGen) to discover the likely cause of a child’s rare type of severe muscle weakness. The child was one of six cases that TGen sequenced, or decoded, the genes of patients with Neuromuscular Disease (NMD) and was then …

Read More »

Takeda Partners with BioXcel to Repurpose Compounds for Rare Diseases, Utilizing BioXcel’s Technology

Today, BioXcel announced that it has teamed up with Takeda’s US-based global development group to repurpose assets into new therapies for rare diseases. BioXcel, a global leader in providing cloud-based Pharma big data solutions for discovering novel products, said that it has entered into a partnership with Takeda Development Center …

Read More »

Quest Diagnostics Announces the Launch of New Technology Solutions

Quest Diagnostics announced that it will unveil a suite of new technology solutions, featuring interactive Insights by Care360 reports and IntelliTest Analytics. The leading provider of diagnostics information services said that it will launch its new technology solutions during the HIMSS 2015 Annual Conference & Exhibition, the industry’s largest health …

Read More »

Interoperability of Healthcare IT: Time to Bring in the Big Guns to Big Data?

Providers, regulators and policy makers agree: The interoperability, i.e., the ability to integrate disparate data systems, in healthcare technology has become an urgent need. Executives at one company in suburban Washington, D.C. think the answer lies in the same technologies that have been used in the defense industry to identify …

Read More »

Research Initiative Aims to Uncover First Biomarker for Pancreatic Cancer

Small Boston-based biotech, Berg Pharma, is collaborating with hospitals and research teams to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer. The cross-sector collaboration includes Berg, a biopharmaceutical company committed to uncovering health solutions through a data driven, biological research approach; the Cancer Center at …

Read More »